Bioorthogonal CRISPR/Cas9-Drug Conjugate: A Combinatorial Nanomedicine Platform. [PDF]
Here, a nanomedicine platform based on bioorthogonal CRISPR/Cas9‐drug conjugates, which can be self‐delivered in vivo and exert strong anti‐tumor effects upon gene editing and chemotherapy is developed. The current development provides a powerful strategy that can be widely applied for the therapy of human diseases such as cancer and genetic disorders.
Beha MJ +9 more
europepmc +2 more sources
Olaparib synergy screen reveals Exemestane induces replication stress in triple-negative breast cancer. [PDF]
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Yusoh NA +5 more
europepmc +2 more sources
Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors. [PDF]
Abstract Breakpoint cluster region‐Abelson (BCR::ABL1) gene fusion is an essential oncogene in both chronic myeloid leukemia (CML) and Philadelphia‐positive (Ph+) B‐cell acute lymphoblastic leukemia (B‐ALL). While tyrosine kinase inhibitors (TKIs) are effective in up to 95% of CML patients, 50% of Ph+ B‐ALL cases do not respond to treatment or relapse.
Komorowski L +13 more
europepmc +2 more sources
Abstract This paper discusses a novel approach for exploiting emotions and situation‐aware software adaptation methods for individualizing some of the touch points of the digital customer journey and thereby optimizing customer experience and effectiveness of e‐commerce applications.
Christian Märtin +2 more
wiley +1 more source
Artificial intelligence-assisted ultrasound-guided regional anaesthesia: An explorative scoping review. [PDF]
Abstract Purpose The present study reviews the available scientific literature on artificial intelligence (AI)‐assisted ultrasound‐guided regional anaesthesia (UGRA) and evaluates the reported intraprocedural parameters and postprocedural outcomes.
Marino M +7 more
europepmc +2 more sources
Unmatched Cell Line Collections Are Not Optimal for Identification of PARP Inhibitor Response and Drug Synergies. [PDF]
ABSTRACT PARP inhibitors show great efficacy in BRCA1/2‐mutated patients, but many preclinical studies, including combination therapies, fail to translate clinically, likely due to the limitations of preclinical models. This brief report aimed to identify appropriate cell line models to investigate PARP inhibitor sensitivity and synergies. An in silico
Phan Z, Fernandez KJ, Caldon CE.
europepmc +2 more sources
Towards Intensional Answers to OLAP Queries for Analytical Sessions [PDF]
International audienceOne of the problems in analyzing large multidimensional databases through OLAP sessions is that decision makers can be overwhelmed by the size of query answers, while they need a concise summary of data.
Marcel, Patrick +7 more
core +1 more source
Benchmarking Exploratory OLAP [PDF]
Supporting interactive database exploration (IDE) is a problem that attracts lots of attention these days. Exploratory OLAP (On-Line Analytical Processing) is an important use case where tools support navigation and analysis of the most interesting data, using the best possible perspectives.
Djedaini, Mahfoud +4 more
openaire +2 more sources
Gestão do Conhecimento Utilizando o Dw/Olap Aplicado nas Organizações [PDF]
Neste trabalho são feitas quatro abordagens. Na primeira apresenta-se a disciplina de Gestão do Conhecimento, onde se encontra definições, o papel da TI, sucessos e possíveis falhas na implantação de projetos da Gestão do Conhecimento.
Perfeito, Juarez +3 more
core
Understandability, reuse, and maintainability of analytical queries belong to the key challenges of Data Warehousing, especially in settings where a large number of business analysts work together and need to share knowledge.
Anderlik, S. +5 more
core +1 more source

